Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Jandl, K; Marsh, LM; Mutgan, AC; Crnkovic, S; Valzano, F; Zabini, D; Hoffmann, J; Foris, V; Gschwandtner, E; Klepetko, W; Prosch, H; Flick, H; Brcic, L; Kern, I; Heinemann, A; Olschewski, H; Kovacs, G; Kwapiszewska, G.
Impairment of the NKT-STAT1-CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis.
Am J Respir Crit Care Med. 2022; 206(8):981-998 Doi: 10.1164/rccm.202201-0142OC
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Jandl Katharina
Kwapiszewska-Marsh Grazyna
Co-authors Med Uni Graz
Brcic Luka
Crnkovic Slaven
Flick Holger
Foris Vasile
Gschwandtner Elisabeth
Heinemann Akos
Hoffmann Julia
Kovacs Gabor
Marsh Leigh
Mutgan Redolfi Ayse Ceren
Olschewski Horst
Valzano Francesco
Zabini Diana
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Rationale: Pulmonary hypertension (PH) is a common, severe comorbidity in interstitial lung diseases such as pulmonary fibrosis (PF), and it has limited treatment options. Excessive vascular fibrosis and inflammation are often present in PH, but the underlying mechanisms are still not well understood. Objectives: To identify a novel functional link between natural killer T (NKT) cell activation and vascular fibrosis in PF-PH. Methods: Multicolor flow cytometry, secretome, and immunohistological analyses were complemented by pharmacological NKT cell activation in vivo, in vitro, and ex vivo. Measurements and Main Results: In pulmonary vessels of patients with PF-PH, increased collagen deposition was linked to a local NKT cell deficiency and decreased IL-15 concentrations. In a mouse model of PH caused by lung fibrosis, pharmacological NKT cell activation using a synthetic α-galactosylceramide analog (KRN7000) restored local NKT cell numbers and ameliorated vascular remodeling and right ventricular systolic pressure. Supplementation with activated NKT cells reduced collagen deposition in isolated human pulmonary arterial smooth muscle cells (hPASMCs) and in ex vivo precision-cut lung slices of patients with end-stage PF-PH. Coculture with activated NKT cells induced STAT1 signaling in hPASMCs. Secretome analysis of peripheral blood mononuclear cells identified CXCL9 and CXCL10 as indicators of NKT cell activation. Pharmacologically, CXCL9, but not CXCL10, potently inhibited collagen deposition in hPASMCs via the chemokine receptor CXCR3. Conclusions: Our results indicate that the absence of NKT cells impairs the STAT1-CXCL9-CXCR3 axis in PF-PH and that restoration of this axis by NKT cell activation may unravel a novel therapeutic strategy to target vascular fibrosis in interstitial lung disease.
Find related publications in this database (using NLM MeSH Indexing)
Animals - administration & dosage
Humans - administration & dosage
Mice - administration & dosage
Chemokine CXCL9 - therapeutic use
Collagen - metabolism
Hypertension, Pulmonary - drug therapy
Interleukin-15 - therapeutic use
Leukocytes, Mononuclear - metabolism
Lung Diseases, Interstitial - pathology
Pulmonary Fibrosis - administration & dosage
STAT1 Transcription Factor - administration & dosage
Natural Killer T-Cells - administration & dosage

Find related publications in this database (Keywords)
interstitial lung disease
immunotherapy
vascular remodeling
vascular fibrosis
© Med Uni GrazImprint